May 15, 2020 by Chain Drug Review
COVID-19, IRI
Business, Leading Headlines, Retail News
CHICAGO — As IRI continues to monitor the pandemic, its latest analysis revisits “The Changing Shape of the Demand Curve (Part 2)” with a closer look at the meat industry and the varying behaviors and attitudes of millennials. COVID-19 continues its reach beyond personal health to CPG demand, inflation, supply chain and more. IRI is tracking
May 6, 2020 by Chain Drug Review
Dr. Krishnakumar Davey, eighth annual Boston Consulting Group (BCG)/IRI CPG, IRI
Business, Leading Headlines, Retail News, Supplier News
CHICAGO — The U.S. consumer packaged goods industry increased by 2.2% in 2019, outpacing 2018 growth of 2.0%, according to the eighth annual Boston Consulting Group (BCG)/IRI CPG study released at the end of March. The growth was driven exclusively by pricing adjustments in the face of declining average volumes across measured channels. Despite the
May 1, 2020 by Chain Drug Review
Boston Consulting Group (BCG), COVID-19 trends, IRI
Business, Leading Headlines, Retail News
CHICAGO — IRI is continuing to collaborate with its partners at the Boston Consulting Group (BCG) to analyze the latest consumer purchase trends in Italy, France, Germany, Netherlands, New Zealand, Spain, U.K. and U.S. The company just updated the report, “Consumer Spending Tracker: COVID-19 Impact,” to capture the most recent insights. Key highlights from the research
April 30, 2020 by Chain Drug Review
COVID-19, IRI
Business, Leading Headlines, Retail News
CHICAGO — As IRI continues to monitor the pandemic, we are launching a special four-part series, “Recession-Proof Your Business.” While COVID-19 is unique in scope, social and business implications, the company already sees that consumer behavior mirrors that of past recessions, including the Great Recession of 2008-2009. The first installment of their series takes a
April 24, 2020 by Chain Drug Review
Boston Consulting Group (BCG), COVID-19 shopping trends, IRI
Business, Leading Headlines, Retail News
CHICAGO — IRI is continuing to collaborate with its partners at the Boston Consulting Group (BCG) to analyze the latest consumer purchase trends in Italy, France, Germany, Netherlands, New Zealand, Spain, U.K. and U.S. The firm just updated the report, “Consumer Spending Tracker: COVID-19 Impact,” to capture the most recent insights. Key highlights from the research
April 10, 2020 by Chain Drug Review
coronavirus (COVID-19) pandemic, IRI
Business, Leading Headlines, Retail News
CHICAGO — As IRI continues to monitor COVID-19, its latest analysis, “Consumers Provide Pessimistic View of Coming Months,” finds that U.S. consumers are becoming increasingly concerned about the health crisis and the long-term economic impact. COVID-19 U.S. Implications With nearly 60% of consumers believing the COVID-19 pandemic will last more than three months and 92% believing
April 3, 2020 by Chain Drug Review
Boston Consulting Group (BCG), COVID-19, IRI
Business, Leading Headlines, Retail News, Supplier News
CHICAGO — IRI is continuing to collaborate with their partners at the Boston Consulting Group (BCG) to analyze the latest consumer purchases in Italy, France, Germany, New Zealand, the U.K and the U.S. The company just updated the report “COVID-19 Impact: Consumer Spending Tracker” to capture the most recent insights. Key highlights from the research include:
March 27, 2020 by Chain Drug Review
Boston Consulting Group (BCG), consumer spending, COVID-19, IRI
Business, Leading Headlines, Retail News
CHICAGO — IRI is continuing to collaborate with their partners at the Boston Consulting Group (BCG) to analyze the latest consumer purchases in Italy, France, New Zealand, the U.K and the U.S. The company just updated the report, “COVID-19 Impact: Consumer Spending Tracker,” to capture the most recent insights. Key highlights from the research include: Trends
March 4, 2020 by Chain Drug Review
2020 IRI Growth Summit, IRI
Business, Leading Headlines
CHICAGO — IRI announced on Wednesday that the IRI Growth Summit originally scheduled for March 30 – April 1, 2020, in Orlando, Fla. has been cancelled due to the coronavirus outbreak. In making the announcement, the company issued the following statement: “We have been closely monitoring and evaluating the rapidly evolving global COVID-19 virus outbreak
January 28, 2020 by Chain Drug Review
CPG industry, IRI, IRI's latest Consumer Connect survey, Joan Driggs
Business, Leading Headlines, Retail News
CHICAGO — According to IRI’s latest Consumer Connect survey, dollar stores and digital retailers are the primary beneficiaries as consumers shift their shopping habits to save time, effort and money. IRI analyzes this shift in a January 27 report titled “Channel Trends in CPG Today,” which finds that consumers remain confident about their financial wellbeing.
December 12, 2019 by Chain Drug Review
Harvey Goldhersz, IRI, Jen Bukich, Kantar
Business, Leading Headlines, Supplier News
NEW YORK — IRI and Kantar are joining forces to help consumer packaged goods companies measure and optimize their marketing programs for both short-term sales gains and long-term brand health. The companies this week launched what they’re calling a closed-loop solution that combines IRI sales data and Kantar brand insights to deliver a “highly predictive,
November 7, 2019 by Chain Drug Review
IRI, Joan Driggs, Private Label Brands
Business, Leading Headlines, Retail News, Supplier News
CHICAGO — Although 57% of consumers say their financial health is good, fears of a recession are driving slightly less consumer confidence in Q3 2019, according to the latest IRI Consumer Connect Survey results released today. Expecting to face a recession — or, perhaps more likely, a “semi-recession” — consumers are increasing their savings as
September 13, 2019 by Chain Drug Review
Andrew Appel, Dimitri Panayotopoulos, IRI, Jeffrey Ansell, Rick Kash
Business, Leading Headlines, Supplier News
CHICAGO — IRI announced that Rick Kash and Dimitri Panayotopoulos will join the company’s board of directors, effective immediately. IRI is a portfolio company of Vestar Capital Partners and New Mountain Capital. “We are very pleased to have Rick and Dimitri — two highly accomplished consumer goods professionals who are well respected in the industry
March 18, 2019 by Chain Drug Review
CHPA, IRI, O-T-Cs
Featured Articles, Leading Headlines, Supplier News
WASHINGTON — Over-the-counter (O-T-C) medicines save the U.S. health care system nearly $146 billion a year, a new study has found. The report, “Value of O-T-C Medicines to the U.S. Healthcare System,” which was released by the Consumer Healthcare Products Association (CHPA), found that, on average, each dollar spent on O-T-Cs saves the national system